European biotech industry group
EuropaBio ("The European Association for Bioindustries") is Europe's largest and most influential biotech industry group, whose members include leading large-size healthcare and industrial biotechnology companies. EuropaBio is located in Brussels, Belgium. The organisation was initiated in 1996 to represent the interests of the biotechnology industry at the European level, and therefore influence legislation that serves the interests of biotechnology companies in Europe.
Activity and goals.
EuropaBio is engaged in dialogue with the European Parliament, the European Commission, and the Council of Ministers to influence legislation on biotechnology.
EuropaBio represents two sectors of the biotech industry. 
EuropaBio's stated goals are:
EuropaBio's primary focus is the European Union but because of the global character of the biotech business, it also represents its members in transatlantic and worldwide forums.
Organisation.
EuropaBio has a board of management made up of representatives from among its industry members. Since 2023, Dr. Sarah Reisinger representing dsm-firmenich is chair of the board.
The board is assisted by sectoral councils representing the main segments of EuropaBio – healthcare (red biotech), and industrial (white biotech).
Additionally, National Associations are represented through the National Associations Council.
Experts from member companies and national associations participate in EuropaBio's working groups which cover a very wide range of issues and areas of concern of biotech enterprises.
Since November 2020 EuropaBio Director General is Dr. Claire Skentelbery.
Members.
In 2021, the association represents 79 corporate and associate members and BioRegions, and 17 national biotechnology associations in turn representing over 1800 biotech SMEs.
Citations.
 ;templatestyles src="Reflist/styles.css" / ;